Details of the Drug Reposition

General Information of This Drug (ID: DMMNLWI)

Drug Name	AGS-003 DMMNLWI

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Renal cell carcinoma	DISQZ2X8	2C90	Phase 2	[1]
Migraine	DISQ8RM8	8A80	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01482949) A Rollover Protocol for Subjects Previously Treated With AGS-003. U.S. National Institutes of Health.